These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19672858)

  • 21. Deriving valid population-based cancer survival estimates in the presence of nonnegligible proportions of cancers notified by death certificates only.
    Brenner H; Holleczek B
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2480-6. PubMed ID: 21960691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
    Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
    Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating survival in newly diagnosed cancer patients: use of computer simulations to evaluate performances of different approaches in a wide range of scenarios.
    Rashid I; Marcheselli L; Federico M
    Stat Med; 2008 May; 27(12):2145-58. PubMed ID: 18095273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland.
    Brenner H; Söderman B; Hakulinen T
    Int J Epidemiol; 2002 Apr; 31(2):456-62. PubMed ID: 11980816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are patients diagnosed with breast cancer before age 50 years ever cured?
    Brenner H; Hakulinen T
    J Clin Oncol; 2004 Feb; 22(3):432-8. PubMed ID: 14691121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer incidence and mortality in France over the period 1978-2000.
    Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990.
    Verhoeven RH; Janssen-Heijnen ML; Saum KU; Zanetti R; Caldarella A; Holleczek B; Brewster DH; Hakulinen T; Horenblas S; Brenner H; Gondos A;
    Eur J Cancer; 2013 Apr; 49(6):1414-21. PubMed ID: 23231984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Childhood cancer survival in France, 2000-2008.
    Lacour B; Goujon S; Guissou S; Guyot-Goubin A; Desmée S; Désandes E; Clavel J
    Eur J Cancer Prev; 2014 Sep; 23(5):449-57. PubMed ID: 25010837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival among adolescents and young adults with cancer in Germany and the United States: an international comparison.
    Gondos A; Hiripi E; Holleczek B; Luttmann S; Eberle A; Brenner H;
    Int J Cancer; 2013 Nov; 133(9):2207-15. PubMed ID: 23616284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
    Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
    Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model based period analysis of absolute and relative survival with R: data preparation, model fitting and derivation of survival estimates.
    Holleczek B; Brenner H
    Comput Methods Programs Biomed; 2013 May; 110(2):192-202. PubMed ID: 23116692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Model based hybrid analysis of cancer patient survival.
    Brenner H; Hakulinen T
    Eur J Cancer; 2007 Mar; 43(5):921-7. PubMed ID: 17329096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer survival differences between European countries and an urban population from the Philippines.
    Redaniel MT; Laudico A; Mirasol-Lumague MR; Gondos A; Brenner H
    Eur J Public Health; 2011 Apr; 21(2):221-8. PubMed ID: 20410159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis.
    Gondos A; Bray F; Hakulinen T; Brenner H;
    Ann Oncol; 2009 Mar; 20(3):564-73. PubMed ID: 19066327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-to-date long-term survival curves of patients with cancer by period analysis.
    Brenner H; Hakulinen T
    J Clin Oncol; 2002 Feb; 20(3):826-32. PubMed ID: 11821467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cancer survival gap between elderly and middle-aged patients in Europe is widening.
    Quaglia A; Tavilla A; Shack L; Brenner H; Janssen-Heijnen M; Allemani C; Colonna M; Grande E; Grosclaude P; Vercelli M;
    Eur J Cancer; 2009 Apr; 45(6):1006-16. PubMed ID: 19121578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System.
    Steliarova-Foucher E; Arndt V; Parkin DM; Berrino F; Brenner H
    Ann Oncol; 2007 Sep; 18(9):1554-60. PubMed ID: 17698836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updating long-term childhood cancer survival trend with period and mixed analysis: good news from population-based estimates in Italy.
    Zuccolo L; Dama E; Maule MM; Pastore G; Merletti F; Magnani C
    Eur J Cancer; 2006 May; 42(8):1135-42. PubMed ID: 16630713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees in Europe: From roots to fruits.
    Coebergh JW; van den Hurk C; Louwman M; Comber H; Rosso S; Zanetti R; Sacchetto L; Storm H; van Veen EB; Siesling S; van den Eijnden-van Raaij J
    Eur J Cancer; 2015 Jun; 51(9):1050-63. PubMed ID: 25934439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proportion cured models applied to 23 cancer sites in Norway.
    Cvancarova M; Aagnes B; Fosså SD; Lambert PC; Møller B; Bray F
    Int J Cancer; 2013 Apr; 132(7):1700-10. PubMed ID: 22927104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.